Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives

Area of Science:

• Pharmacology
• Molecular Biology
• Drug Discovery

Background:

• Adenosine receptors (ARs) are G-protein coupled receptors (GPCRs) activated by adenosine.
• Four subtypes exist: A1, A2A, A2B, and A3 receptors.
• ARs are widely distributed and play roles in numerous physiological functions, making them therapeutic targets for conditions like cardiac diseases, cancer, Parkinson's disease, inflammation, and glaucoma.

Purpose of the Study:

• To review the A2A receptor (A2AAR) subtype of adenosine receptors.
• To discuss recent advances in understanding A2AAR structure, properties, and therapeutic potential.
• To highlight methods for studying A2AAR and molecular modeling in A2AAR ligand design.

Main Methods:

• Literature review of adenosine receptor research.
• Analysis of A2AAR structure and function.
• Overview of recent advancements in A2AAR research methodologies.
• Examination of molecular modeling techniques for A2AAR ligand development.

Main Results:

• Extensive research has identified numerous AR agonists and antagonists.
• The A2AAR subtype presents significant therapeutic potential.
• Molecular modeling aids in the rational design of A2AAR-targeting drugs.

Conclusions:

• The A2AAR is a promising target for drug development across various pathological conditions.
• Advancements in research methods and molecular modeling are accelerating the discovery of A2AAR ligands.
• Further investigation into A2AAR modulation holds potential for novel therapeutic strategies.